Authors: Brockstein, B Haraf, DJ Stenson, K Sulzen, L Witt, ME Weichselbaum, RW Vokes, EE

Citation: B. Brockstein et al., A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer, ANN ONCOL, 11(6), 2000, pp. 721-728

Authors: Vokes, EE Kies, MS Haraf, DJ Stenson, K List, M Humerickhouse, R Dolan, ME Pelzer, H Sulzen, L Witt, ME Hsieh, YC Mittal, BB Weichselbaum, RR

Citation: Ee. Vokes et al., Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer, J CL ONCOL, 18(8), 2000, pp. 1652-1661

Authors: Humerickhouse, RA Dolan, ME Haraf, DJ Brockstein, B Stenson, K Kies, M Sulzen, L Ratain, MJ Vokes, EE

Citation: Ra. Humerickhouse et al., Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrentor advanced head and neck cancer, CLIN CANC R, 5(2), 1999, pp. 291-298

Authors: Haraf, DJ Kies, M Rademaker, AW Stenson, K Mittal, B Pelzer, H Wenig, B Witt, ME Sulzen, L Weichselbaum, RR Vokes, EE

Citation: Dj. Haraf et al., Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer, J CL ONCOL, 17(2), 1999, pp. 638-644